Antigen News and Research

RSS

CAR T therapy can lead to long-lasting remissions in patients with r/r diffuse large B-cell lymphoma

In an update to a global clinical trial stretching from Philadelphia to four continents, the chimeric antigen receptor (CAR) T cell therapy Kymriah (tisagenlecleucel, formerly CTL019) led to long-lasting remissions in patients with relapsed/refractory (r/r) diffuse large B-cell lymphoma (DLBCL).

3 Dec 2018

The Native Antigen Company launches ground-breaking Zika virus immunoassays

The Native Antigen Company has launched a series of ground-breaking immunoassays for Zika virus, offering researchers in academia, public health and drug discovery the capability to work with unprecedented levels of specificity and sensitivity.

29 Nov 2018

Research may pave way for development of potent weapons against cancer

Despite significant advances in cancer research, the disease continues to exact a devastating toll. Because cancer is a disease of the body's own cells, which mutate and develop under evolutionary pressure, conventional treatments like chemotherapy and radiation often leave behind a residue of resistant cells that go on to expand and wreak havoc.

27 Nov 2018

Breakthrough achieved in decoding multi-resistant pathogens

Researchers at the University of Tübingen and the German Center for Infection Research have achieved a breakthrough in the decoding of multi-resistant pathogens.

26 Nov 2018

Abramson Cancer Center becomes the 28th member institution of National Comprehensive Cancer Network

The Abramson Cancer Center (ACC) at the University of Pennsylvania announced today that it is joining the National Comprehensive Cancer Network (NCCN) as its 28th member institution.

20 Nov 2018

Scientists identify novel target for neuron regeneration, functional recovery in spinal cord injury

Restoring the ability to walk following spinal cord injury requires neurons in the brain to reestablish communication pathways with neurons in the spinal cord.

20 Nov 2018

FIND explores new diagnostic assays for confirmatory HCV diagnosis in community settings

The Foundation for Innovative New Diagnostics today announced awards to support the development, manufacture and feasibility testing of two prototype hepatitis C virus core antigen immunoassays for confirmatory HCV diagnosis at the point of care.

16 Nov 2018

New method to extend cell division and immortalization of avian-derived cells

The number of critically endangered animals has been increasing in recent years. According to data from the International Union for the Conservation of Nature, 1375 avian species are categorized as being endangered animals, and around 12% of the endangered species are avian.

16 Nov 2018

Study sheds light on mechanisms that prevent autoimmune attack

Understanding the mechanisms that prevent our immune system damaging healthy cells, whilst fighting infection and cancer, could lead to the development of novel immune-regulating treatments.

14 Nov 2018

NIH researchers shed light on causes of HBV-associated acute liver failure

National Institutes of Health scientists and their collaborators found that hepatitis B virus-associated acute liver failure--a rare condition that can turn fatal within days without liver transplantation--results from an uncommon encounter between a highly mutated HBV variant and an unusual immune response in the patient's liver that is mainly sustained by antibody-producing B cells.

14 Nov 2018

FDA announces emergency use authorization of Ebola fingerstick test with portable reader

Today, the U.S. Food and Drug Administration announced that an emergency use authorization has been issued for a rapid, single-use test for the detection of Ebola virus.

12 Nov 2018

UCI researchers accelerate and simplify directed evolution bioengineering technique

In a process known as directed evolution, scientists reengineer biomolecules to find ones that perform beneficial new functions. The field is revolutionizing drug development, chemical engineering and other applications, but to realize its promise involves painstaking and time-consuming laboratory work.

9 Nov 2018

Precisely targeted prostate cancer radiotherapy possible with nuclear medicine imaging

Current standard imaging techniques for initial staging of prostate cancer often underestimate the extent of disease beyond the prostate.

9 Nov 2018

Scientists move closer to gonorrhea vaccine after large-scale proteomic study

In a study of proteins historic in its scope, researchers at Oregon State University have pushed closer both to a vaccine for gonorrhea and toward understanding why the bacteria that cause the disease are so good at fending off antimicrobial drugs.

8 Nov 2018

Monash researchers provide insight into intricate peptide changes affecting immune system

Human leukocyte antigen molecules are a group of proteins that help the immune system identify foreign invaders such as viruses and bacteria and which impact a wide variety of clinical outcomes including infection and cancer.

8 Nov 2018

New study sheds light on how CAR T cell therapy works

Cancer remains the second-leading cause of death in the United States. This year, an estimated 1.7 million new cases will be diagnosed, with nearly 610,000 people expected to die from the disease, according to the National Cancer Institute.

8 Nov 2018

New immunotherapy screening prototype helps physicians to effectively target tumors

A new immunotherapy screening prototype developed by University of California, Irvine researchers can quickly create individualized cancer treatments that will allow physicians to effectively target tumors without the side effects of standard cancer drugs.

7 Nov 2018

TGen and City of Hope announce letter of intent to develop new cell therapy manufacturing facility

City of Hope, a world-renowned independent cancer research and treatment center, and its affiliate, Translational Genomics Research Institute, have announced a letter of intent to develop a state-of-the-art cell therapy manufacturing facility in the Phoenix Metropolitan Area, a move that would improve the speed at which stem cell research and cancer treatment is delivered.

5 Nov 2018

Amgen announces presentation of new clinical data showcasing early oncology pipeline at ASH 2018

Amgen today announced that new clinical data will be presented at the 60th American Society of Hematology Annual Meeting & Exposition in San Diego, Dec. 1-4, 2018. Data across an array of malignancies will be featured in 45 abstracts, including nine oral presentations, from the Company’s broad portfolio andearly-stage pipeline.

From AMGEN 5 Nov 2018

TGen, City of Hope to develop cell therapy manufacturing facility in Phoenix

City of Hope, a world-renowned independent cancer research and treatment center, and its affiliate, Translational Genomics Research Institute (TGen), have announced a letter of intent to develop a state-of-the-art cell therapy manufacturing facility in the Phoenix Metropolitan Area, a move that would improve the speed at which stem cell research and cancer treatment is delivered.

2 Nov 2018

Antigen News and Research

CAR T therapy can lead to long-lasting remissions in patients with r/r diffuse large B-cell lymphoma

The Native Antigen Company launches ground-breaking Zika virus immunoassays

Research may pave way for development of potent weapons against cancer

Breakthrough achieved in decoding multi-resistant pathogens

Abramson Cancer Center becomes the 28th member institution of National Comprehensive Cancer Network

Scientists identify novel target for neuron regeneration, functional recovery in spinal cord injury

FIND explores new diagnostic assays for confirmatory HCV diagnosis in community settings

New method to extend cell division and immortalization of avian-derived cells

Study sheds light on mechanisms that prevent autoimmune attack

NIH researchers shed light on causes of HBV-associated acute liver failure

FDA announces emergency use authorization of Ebola fingerstick test with portable reader

UCI researchers accelerate and simplify directed evolution bioengineering technique

Precisely targeted prostate cancer radiotherapy possible with nuclear medicine imaging

Scientists move closer to gonorrhea vaccine after large-scale proteomic study

Monash researchers provide insight into intricate peptide changes affecting immune system

New study sheds light on how CAR T cell therapy works

New immunotherapy screening prototype helps physicians to effectively target tumors

TGen and City of Hope announce letter of intent to develop new cell therapy manufacturing facility

Amgen announces presentation of new clinical data showcasing early oncology pipeline at ASH 2018

TGen, City of Hope to develop cell therapy manufacturing facility in Phoenix

Industry Focus eBook - Cell biology (5th edition) eBook

Latest eBooks

Editorial Focus eBook - Spatial and single-cell omics (1st edition)

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Industry Focus eBook - Cell biology (5th edition)

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics